biotech · Cervical Spinal Cord Injury · Spinal Cord Injury · LCTX
Lineage Cell Therapeutics
Lineage Cell Therapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Carlsbad, USA HQ
1990 Founded
35 Employees
Public company Type
LCTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Carlsbad, USA
- Founded
- 1990
- Employees
- 35
- Programs
- 3
- Drugs
- 0
- Patents
- 0
Lineage Cell Therapeutics patents
0 pharmaceutical patents indexed for Lineage Cell Therapeutics. 0 expire within 24 months.
Lineage Cell Therapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Lineage Cell Therapeutics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Lineage Cell Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.